Invention Grant
- Patent Title: Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
-
Application No.: US17394900Application Date: 2021-08-05
-
Publication No.: US11976126B2Publication Date: 2024-05-07
- Inventor: John C. Timmer , Kyle S. Jones , Amir S. Razai , Abrahim Hussain , Katelyn M. Willis , Quinn Deveraux , Brendan P. Eckelman
- Applicant: Inhibrx, Inc.
- Applicant Address: US CA La Jolla
- Assignee: Inhibrx, Inc.
- Current Assignee: Inhibrx, Inc.
- Current Assignee Address: US CA La Jolla
- Agency: McNeill Baur PLLC
- The original application number of the division: US16387754 2019.04.18
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
The disclosure relates generally to molecules that specifically engage death receptor 5 (DR5), a member of the TNF receptor superfamily (TNFRSF). More specifically the disclosure relates to multivalent and multispecific molecules that bind at least DR5.
Public/Granted literature
- US20220064318A1 Multivalent and Multispecific DR5-Binding Fusion Proteins Public/Granted day:2022-03-03
Information query
